Parkinson disease: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• SNCA 10
• LRRK2 7
• NRF2 1
• GBA1 13
• NLRP3 1
• PINK1 1
• AKT 0
• PI3K 0
• GLP-1 0
• STING 0
• BDNF 1
• mTOR 0
• SIRT1 0
• TLR4 0
• PPAR 0
• AMPK 1
• TP53 0
• GPX4 0
• MAPK 0
• MAPT 0
• TNF 0
• APOE 1
• HMGB1 0
• JNK 0
• ERK 0
• HSP90 1
• JAK 0
• STAT3 0
• TREM2 0
• HDAC 0
• TDP-43 1
• NMDA 0
• TFEB 0
• HIF-1 1
• IL-1 0
• PARP 0
• CTNNB1 0
• GIP 0
• IL-17 0
• PCSK9 0
• ACE2 0
• AQP4 0
• BCL-2 0
• CSF1R 0
• FTO 0
• PKM2 0
• SGLT2 0
• CD38 0
• COX-2 0
• DPP-4 0
• G6PD 0
• IDO1 0
• PDE4 0
• PTEN 0
• YAP 0
• ALK 0
• APP 0
• ATM 0
• BACE1 0
• C9orf72 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 3,889 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  High-Dose Ambroxol in GBA1-Related Parkinson

  NCT06193421· Agyany Pharma LTD· Updated 9 Nov 2026

  “Sponsor's decision”Registry text, quoted unchanged. Source

• Terminated

  Robotic Gait Rehabilitation in Parkinson's Disease

  NCT05218187· Indiana University· Updated 5 Nov 2026

  “The PI was no longer able to successfully recruit participants and funding was depleted.”Registry text, quoted unchanged. Source

• Terminated

  Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach

  NCT06378619· Consorci Sanitari de l'Alt Penedès i Garraf· Updated 28 Oct 2026

  “Poor recruitment”Registry text, quoted unchanged. Source

• Terminated

  Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  NCT02897063· Vanderbilt University Medical Center· Updated 23 Oct 2026

  “enrollment goal was not met.”Registry text, quoted unchanged. Source

• Terminated

  Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

  NCT06003608· Nimble Science Ltd.· Updated 20 Oct 2026

  “Study recruitment phase exceeded the time allotted”Registry text, quoted unchanged. Source

• Suspended

  Terazosin And Metabolic Energetics in Parkinson's Disease

  NCT07464028· Ergun Y. Uc· Updated 9 Oct 2026

  “Study not funded”Registry text, quoted unchanged. Source

• Withdrawn

  Terazosin And Metabolic Engagement in Parkinson's Disease

  NCT07288450· Nandakumar Narayanan· Updated 7 Oct 2026

  “Not Funded”Registry text, quoted unchanged. Source

• Terminated

  Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease

  NCT07313176· Britannia Pharmaceuticals Ltd.· Updated 2 Oct 2026

  “Following a reassessment, it was concluded that continuation of the study would no longer achieve its scientific objectives originally set out for the study.”Registry text, quoted unchanged. Source

• Withdrawn

  The Parkinson's Disease Case-Control Study

  NCT06848192· Westlake University· Updated 29 Sept 2026

  “Due to challenges in obtaining faecal samples from patients with Parkinson's disease, a population frequently affected by constipation.”Registry text, quoted unchanged. Source

• Suspended

  Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease

  NCT05482126· University of Alabama at Birmingham· Updated 24 Sept 2026

  “Suspending since no longer working participants at this time or enrolling new ones.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control

  NCT07056361· Jorge Gonzalez-Martinez· Source

• Closed Loop DBS Implanted RC+S Study

  NCT03815656· Dennis Turner, M.D.· Source

• DBS Imaging-based vs. Threshold Assessment-based Programming

  NCT06223399· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source

• Identification of Cognitive and Motor Changes in Individuals With and Without Parkinson's Disease Using Hemoencephalography

  NCT07931677· Federal University of Uberlandia· Source

• RehaBEElitation - Serious Game-Based Experimental Protocol to Improve Manual Dexterity in Individuals With Parkinson's Disease

  NCT07928050· Federal University of Uberlandia· Source

• Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

  NCT07781644· Hoffmann-La Roche· Source

• An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

  NCT06996652· Yale University· Source

• Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

  NCT07642908· University of Michigan· Source

• Voluntary Activation During Isokinetic Contractions in Subjects With Neuromotor Disorders

  NCT04607174· Istituto Auxologico Italiano· Source

• Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation

  NCT04897256· Oregon Health and Science University· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 23
• Organoids 19
• Mendelian Randomization Analysis 66
• CRISPR-Cas Systems 15
• Gene Expression Profiling 76
• Sequence Analysis, RNA 7
• Whole Genome Sequencing 7
• Exome Sequencing 12
• Proteomics 70
• Metabolomics 35
• Mass Spectrometry 12
• Flow Cytometry 4
• Immunohistochemistry 50
• Liquid Biopsy 3
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 103
• Magnetic Resonance Imaging 369
• Machine Learning 141
• Deep Learning 72
• Cohort Studies 185
• Genome-Wide Association Study 83

• Estimating bone marrow adiposity from head MRI and identifying its genetic architecture.

  Elife, Nov 2026

• Cerebellar Glutamate Chemical Exchange Saturation Transfer Alterations Correlated With Cognitive Impairment in Parkinson's Disease.

  NMR Biomed, Nov 2026

• Volumetric and Intrastructural Characterization of the Substantia Nigra Using Optimized Synthetic MR Images Derived From Quantitative T1 Maps at 3 T.

  NMR Biomed, Nov 2026

• Understanding Glymphatic's Role In Proteinopathies (GRIP): A single centre case-control study protocol.

  PLoS One, Oct 2026

• Cortical thinning and altered directed connectivity in Parkinson's disease: a cortical thickness-guided voxel-wise granger causality study.

  Front Neurol, Oct 2026

• Locus coeruleus abnormalities on neuromelanin-sensitive MRI in Parkinson's disease: a systematic review and meta-analysis.

  J Neurol, Oct 2026

• Fixed-Sequence OFF-to-ON Differences in Low-Beta State Dynamics in Parkinson's Disease: A Paired Source-Space Resting-State EEG Study.

  Brain Topogr, Oct 2026

• Research on dynamic functional connectivity and graph theoretic features of different motor subtypes in Parkinson's disease based on ICA.

  Front Neurol, Oct 2026

• Hierarchical reorganization of cortical and cerebellar functional gradients in Parkinson's disease.

  Front Neurol, Oct 2026

• Neuromelanin-sensitive magnetic resonance imaging in the diagnosis and assessment of Parkinson's disease.

  Front Neurol, Oct 2026

See which targets of this disease your abstract mentions, and go to the people working on them.